These evidence-based standards focus on three areas: performance, kit standards and usability and laboratory standards:
Performance Highlights
Kit Standards and Usability Highlights
Lab Standards Highlights
The standards were developed by an expert panel supported by Cancer Care Ontario's Program in Evidence-Based Care (PEBC). The FOBT standards are based on published literature, information obtained from other colorectal cancer screening programs, unindexed literature on the Web and kit manufacturers' instructions.
During the first 2 years of the CC program, the FOBT positivity rate has been approximately 4%. Many individuals with a positive FOBT will be found to have pre-cancerous colorectal polyps at colonoscopy. These polyps will be removed during the colonoscopy. FOBT's sensitivity to detect cancer in repeated testing every one to two years is 46%.
The scientific evidence is strongest to support FOBT (Level A)*. Three landmark randomized controlled trials have shown a reduction in colorectal cancer deaths of 16% with FOBT screening combined with colonoscopy for those with a positive FOBT. There are no randomized controlled trials that have evaluated colonoscopy. The evidence for colonoscopy is Level C for those at average risk. So, although colonoscopy is considered the gold-standard test by many, no direct evidence for its use as a screening modality currently exists.
The colonoscopy standards cover three key aspects of colonoscopy: physicians, hospitals and performance. Physician standards outline required experience and training and state that to maintain competency, physicians need to perform a minimum of 200 colonoscopies annually going forward. Hospital standards deal with patient assessment, infection control, monitoring during and after administration of sedation and emergency resuscitation capacity. Performance standards provide detail around acceptable rates of completion and complications and deals with issues such as equipment, perforation rates, sedation, bowel preparation and pathology.
The standards were developed by an exoert panel supported by Cancer Care Ontario's Program in Evidence-Based Care (PEBC). The colonoscopy standards are based on published literature and input from practice leaders, and scientists. The comprehensiveness of these standards makes them the first of their kind in Canada.
To complement the colonoscopy standards, ColonCancerCheck adopted colonoscopy surveillance guidelines outlined in “Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society" that were published in Gastroenterology in 2006.
For more information about ColonCancerCheck, call ServiceOntario INFOline at 1-866-410-5853.
Hours of operation : 8:30am - 5:00pm, Monday to Friday.
TTY 1-800-387-5559.
Email : ColonCancerCheck.moh@ontario.ca or
Visit : Cancer Care Ontario